Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Clinical trials in Utah
654 of 1,734 in-state trials are recruiting (38%); roughly in line with the 37% national average.
According to ClinicalTrials.gov-derived indexes, Utah sits in the lower half of US states by in-state trial count (#31 of 52 states by registered in-state trial count).
Utah: 1,734 US clinical trials with in-state sites, 654 recruiting.
Utah has 1,734 registered US clinical trials with a study site in-state, 654 of them currently recruiting (roughly in line with the 37% national average). 266 of these trials are in Phase 3 (late-stage) and 359 in Phase 2. The most frequently studied condition in Utah is Advanced Solid Tumor, with 31 linked trials.
Lower-half Utah archive
Utah open-enrollment share is 38% (p96 of states with sites; national baseline 37%). Treat this page as a compact local index (mid-volume · high-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
In-line with national open share
Utah tracks 1,734 in-state trials with 654 open (38%), roughly in line with the 37% national average within about 1-2 points of the 37% national figure.
- 38%
- open (near national share)
- 654
- recruiting participants now
- 266
- Phase 3 (late-stage)
- 31
- top: Advanced Solid Tumor
Recruiting share is roughly in line with the 37% national average. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Utah vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
1,734 Top 60% more indexed trials than 40% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Utah on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Utah open-enrollment share matches the national baseline.
654 of 1,734 in-state trials (37.7%) are recruiting, against 37% nationally (+0.7 percentage points). Counts include every study with at least one recorded site in the state.
-
Salt Lake City dominates Utah's trial geography.
Salt Lake City lists 1,392 of 1,734 in-state trials (80.3%) across 414 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Advanced Solid Tumor is the most-studied condition in Utah.
31 of 1,734 in-state trials (1.8%) list Advanced Solid Tumor. That is a local concentration figure, not a national disease ranking.
-
One sponsor accounts for a large share of Utah trials.
University of Utah appears on 301 of 1,734 in-state trials (17.4%). Sponsor identity is as filed on ClinicalTrials.gov.
-
686 Utah trials carry a completed status.
686 of 1,734 (39.6%) are completed. The open share above is the remainder that still lists recruiting.
Where trials run in Utah
Salt Lake City carries 1,392 of Utah's 1,734 indexed trials (80%) across 414 named sites, ahead of Murray at 106. 8 cities clear five listed trials, together naming 571 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Salt Lake City | 1,392 | 414 |
| Murray | 106 | 38 |
| West Valley City | 78 | 32 |
| Ogden | 41 | 27 |
| West Jordan | 29 | 21 |
| Provo | 22 | 16 |
| Layton | 20 | 12 |
| Orem | 16 | 11 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Open-share high
Utah open-enrollment share is 38% (p96 of states with sites; national baseline 37%).
Utah: open share sits in the high tercile of states
Geography is concentrated: Salt Lake City alone accounts for 80% of Utah's indexed trials (1,392 of 1,734), with Murray a distant second at 106.
Phase mix: 266 Phase 3 vs 359 Phase 2 (balanced across stages).
Top condition: Advanced Solid Tumor (31 trials); top sponsor University of Utah (301).
mid-volume · high-open figures (1,734 trials · 38% open) describe registry geography under the open-share high read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Utah on open-enrollment share
Cross-state peers under the open-share high read (mid-volume · high-open), not the same-state browse list.
Similar mid-volume peers (± open share)
- South Carolina · 1,706 trials · 35% recruiting
- Iowa · 1,544 trials · 33% recruiting
- Louisiana · 1,936 trials · 28% recruiting
- Oregon · 1,999 trials · 34% recruiting
- Kansas · 2,080 trials · 29% recruiting
Similar high-open peers (± trial volume)
- Texas · 37% recruiting · 9,951 trials
- Wisconsin · 37% recruiting · 1,760 trials
- West Virginia · 36% recruiting · 277 trials
- Minnesota · 36% recruiting · 4,506 trials
- Virginia · 40% recruiting · 2,598 trials